BELLINGER ANDREW

PrivateCIK: 1864116
Location

CAMBRIDGE, MA

BELLINGER ANDREW (Chief Scientific Officer) sold 90.1% of their position (60K shares) of VERVE THERAPEUTICS, INC. on the open market

Open‑market sale worth $2.12M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 4 sales
InsiderBELLINGER ANDREWCIK 1864116
IssuerVERVE THERAPEUTICS, INC.CIK 1840574
Officer· Chief Scientific Officer
Since Jun 2021
-60K
Net shares
Net seller
$2.12M
Total sold
4
Open market trades
0B · 4S
8
Total transactions
60K acquired · 120K disposed
Non-Derivative Transactions6

Common Stock

Direct
M · Option Exercise

Shares

+20K

Price / share

$1.48

Trade value

$29.60K

% of position

301.7%
9/23/2022
6.63K26.63K

Common Stock

Direct
S · Sale

Shares

6.63K

Price / share

$34.67

Trade value

$229.90K

% of position

24.9%
9/23/2022
26.63K20K

Common Stock

Direct
S · Sale

Shares

13.37K

Price / share

$35.59

Trade value

$475.80K

% of position

66.9%
9/23/2022
20K6.63K

Common Stock

Direct
M · Option Exercise

Shares

+40K

Price / share

$1.48

Trade value

$59.20K

% of position

603.4%
9/23/2022
6.63K46.63K

Common Stock

Direct
S · Sale

Shares

36.80K

Price / share

$35.31

Trade value

$1.30M

% of position

78.9%
9/23/2022
46.63K9.83K

Common Stock

Direct
S · Sale

Shares

3.20K

Price / share

$36.03

Trade value

$115.38K

% of position

32.6%
9/23/2022
9.83K6.63K
Total

Net shares

+0.00

Net value

-$2.03M

Derivative Transactions2

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

40K shares

Shares

40K

Strike price

1.48

Held after

97K

Exercisable

9/23/2022

Stock Option (right to buy)

Direct
M · Option Exercise
Converts to

Common Stock

20K shares

Shares

20K

Strike price

1.48

Held after

23.20K

Exercisable

9/23/2022
BELLINGER ANDREW — Insider Transaction (Form 4) Filed Sep 27, 2022 | Finecho